387 related articles for article (PubMed ID: 27497251)
1. Why targeted therapies are necessary for systemic lupus erythematosus.
Durcan L; Petri M
Lupus; 2016 Sep; 25(10):1070-9. PubMed ID: 27497251
[TBL] [Abstract][Full Text] [Related]
2. Novel Treatments in Lupus.
Kyttaris VC
Curr Rheumatol Rep; 2017 Mar; 19(3):10. PubMed ID: 28265845
[TBL] [Abstract][Full Text] [Related]
3. Belimumab for the treatment of systemic lupus erythematosus.
Jordan N; D'Cruz DP
Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
[TBL] [Abstract][Full Text] [Related]
4. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
Harvey PR; Gordon C
BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
[TBL] [Abstract][Full Text] [Related]
5. Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus.
Hui-Yuen JS; Nguyen SC; Askanase AD
Lupus; 2016 Sep; 25(10):1086-96. PubMed ID: 27497253
[TBL] [Abstract][Full Text] [Related]
6. Belimumab: targeted therapy for lupus.
Chugh PK; Kalra BS
Int J Rheum Dis; 2013 Feb; 16(1):4-13. PubMed ID: 23441766
[TBL] [Abstract][Full Text] [Related]
7. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
Mosak J; Furie R
Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
[TBL] [Abstract][Full Text] [Related]
8. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
9. Biologic therapies in systemic lupus erythematosus.
Bernal CB; Zamora LD; Navarra SV
Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
[TBL] [Abstract][Full Text] [Related]
10. Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells?
Kalunian KC
Lupus; 2016 Sep; 25(10):1097-101. PubMed ID: 27497254
[TBL] [Abstract][Full Text] [Related]
11. Belimumab therapy in systemic lupus erythematosus.
Zouali M; Uy EA
BioDrugs; 2013 Jun; 27(3):225-35. PubMed ID: 23568179
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
Jordan NP; D'Cruz DP
Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
Sthoeger Z; Sharabi A; Mozes E
J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
[TBL] [Abstract][Full Text] [Related]
15. Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review.
Samotij D; Reich A
Biomed Res Int; 2019; 2019():8142368. PubMed ID: 31396534
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapies in systemic lupus erythematosus: successes, failures and future.
Hahn BH
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i64-i66. PubMed ID: 21339222
[TBL] [Abstract][Full Text] [Related]
17. Are lupus animal models useful for understanding and developing new therapies for human SLE?
Moore E; Putterman C
J Autoimmun; 2020 Aug; 112():102490. PubMed ID: 32535128
[TBL] [Abstract][Full Text] [Related]
18. BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.
Vincent FB; Morand EF; Mackay F
Immunol Cell Biol; 2012 Mar; 90(3):293-303. PubMed ID: 22231653
[TBL] [Abstract][Full Text] [Related]
19. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
Lo MS; Tsokos GC
Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
[TBL] [Abstract][Full Text] [Related]
20. New biologic therapy for systemic lupus erythematosus.
Ding HJ; Gordon C
Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
